Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 8/2016

14.06.2016 | Original Article - Cancer Research

Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis

verfasst von: Maria Vincenza Chiantore, Giorgio Mangino, Marco Iuliano, Maria Simona Zangrillo, Ilaria De Lillis, Gabriele Vaccari, Rosita Accardi, Massimo Tommasino, Sandra Columba Cabezas, Maurizio Federico, Gianna Fiorucci, Giovanna Romeo

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Human papillomaviruses (HPVs) are the causative agents of cervical cancer and are also associated with other types of cancers. HPVs can modulate microRNAs (miRNAs) expressed by infected cells. The production of extracellular vesicles is deregulated in cancer, and their cargo delivered to the microenvironment can promote tumorigenesis. The involvement of HPV oncoproteins on miRNA expression in cells and exosomes was analyzed in keratinocytes transduced with E6 and E7 from mucosal HPV-16 or cutaneous HPV-38 (K16 and K38).

Methods

MiRNAs were investigated through the TaqMan Array Human MicroRNA Cards, followed by real-time RT-PCR assay for specific miRNAs. Selected miRNA targets were analyzed by Western blot and correlated to the HPV oncoproteins by specifically silencing E6 and E7 expression. Exosomes, isolated from K16 and K38 supernatants by differential centrifugations, were quantified through the vesicle-associated acetylcholinesterase activity.

Results

MiRNAs deregulated in K16 and K38 cells were identified. HPV-16 and/or HPV-38 E6 and E7 single proteins can modify the expression of selected miRNAs involved in the tumorigenesis, in particular miR-18a, -19a, -34a and -590-5p. The analysis of the content of exosomes isolated from HPV-positive cells revealed the presence of E6 and E7 mRNAs and few miRNAs. MiR-222, a key miRNA deregulated in many cancers, was identified in exosomes from K16 cells.

Conclusions

HPV E6 and/or E7 oncoprotein expression can induce the deregulation of some miRNAs. Through the production and function of exosomes, HPV oncogenes as well as HPV-deregulated miRNAs can potentiate the virus oncogenic effects in the tumor cell microenvironment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Al-Nedawi K, Meehan B, Rak J (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8:2014–2018CrossRefPubMed Al-Nedawi K, Meehan B, Rak J (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8:2014–2018CrossRefPubMed
Zurück zum Zitat Caldeira S, Zehbe I, Accardi R et al (2003) The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 77:2195–2206CrossRefPubMedPubMedCentral Caldeira S, Zehbe I, Accardi R et al (2003) The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 77:2195–2206CrossRefPubMedPubMedCentral
Zurück zum Zitat Chavez-Muñoz C, Kilani RT, Ghahary A (2009) Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. J Cell Physiol 221:221–231. doi:10.1002/jcp.21847 CrossRefPubMed Chavez-Muñoz C, Kilani RT, Ghahary A (2009) Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. J Cell Physiol 221:221–231. doi:10.​1002/​jcp.​21847 CrossRefPubMed
Zurück zum Zitat Chiantore MV, Mangino G, Zangrillo MS, Iuliano M, Affabris E, Fiorucci G, Romeo G (2015b) Role of the microenvironment in tumourigenesis: focus on virus-induced tumors. Curr Med Chem 22:958–974CrossRefPubMed Chiantore MV, Mangino G, Zangrillo MS, Iuliano M, Affabris E, Fiorucci G, Romeo G (2015b) Role of the microenvironment in tumourigenesis: focus on virus-induced tumors. Curr Med Chem 22:958–974CrossRefPubMed
Zurück zum Zitat Corcoran C, Rani S, O’Driscoll L (2014) miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate 74:1320–1334. doi:10.1002/pros.22848 CrossRefPubMed Corcoran C, Rani S, O’Driscoll L (2014) miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate 74:1320–1334. doi:10.​1002/​pros.​22848 CrossRefPubMed
Zurück zum Zitat Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G (2012) miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med 12:27–33CrossRefPubMedPubMedCentral Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G (2012) miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med 12:27–33CrossRefPubMedPubMedCentral
Zurück zum Zitat Honegger A, Leitz J, Bulkescher J, Hoppe-Seyler K, Hoppe-Seyler F (2013) Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int J Cancer 133:1631–1642. doi:10.1002/ijc.28164 CrossRefPubMed Honegger A, Leitz J, Bulkescher J, Hoppe-Seyler K, Hoppe-Seyler F (2013) Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int J Cancer 133:1631–1642. doi:10.​1002/​ijc.​28164 CrossRefPubMed
Zurück zum Zitat Kim HK, Song KS, Park YS et al (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39:184–191CrossRefPubMed Kim HK, Song KS, Park YS et al (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39:184–191CrossRefPubMed
Zurück zum Zitat Komatsu S, Ichikawa D, Takeshita H et al (2014) Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo 28:293–297PubMed Komatsu S, Ichikawa D, Takeshita H et al (2014) Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo 28:293–297PubMed
Zurück zum Zitat Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J (2011) Microvesicles as mediators of intercellular communication in cancer–the emerging science of cellular ‘debris’. Semin Immunopathol 33:455–467. doi:10.1007/s00281-011-0250-3 CrossRefPubMed Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J (2011) Microvesicles as mediators of intercellular communication in cancer–the emerging science of cellular ‘debris’. Semin Immunopathol 33:455–467. doi:10.​1007/​s00281-011-0250-3 CrossRefPubMed
Zurück zum Zitat Sun Y, Zhang B, Cheng J et al (2014) MicroRNA-222 promotes the proliferation and migration of cervical cancer cells. Clin Invest Med 37:E131PubMed Sun Y, Zhang B, Cheng J et al (2014) MicroRNA-222 promotes the proliferation and migration of cervical cancer cells. Clin Invest Med 37:E131PubMed
Zurück zum Zitat Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123–4132. doi:10.1158/0008-5472.CAN-08-0325 CrossRefPubMed Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123–4132. doi:10.​1158/​0008-5472.​CAN-08-0325 CrossRefPubMed
Metadaten
Titel
Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis
verfasst von
Maria Vincenza Chiantore
Giorgio Mangino
Marco Iuliano
Maria Simona Zangrillo
Ilaria De Lillis
Gabriele Vaccari
Rosita Accardi
Massimo Tommasino
Sandra Columba Cabezas
Maurizio Federico
Gianna Fiorucci
Giovanna Romeo
Publikationsdatum
14.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2189-1

Weitere Artikel der Ausgabe 8/2016

Journal of Cancer Research and Clinical Oncology 8/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.